| Heading: |
Asthma: Medical Equipment |
| Question ID: |
1819848 |
| UIN: |
65185 |
| House: |
Commons |
| Date tabled: |
2025-07-04 |
| Asking Member ID: |
5357 |
| Asking Member display name: |
Ayoub Khan
|
| Asking Member handle: |
AyoubKhanMP
|
| Asking Member Twitter reference: |
@AyoubKhanMP
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 3 July 2025 to Question 62444 on Asthma: Medical Equipment, what recent discussions his Department has had with pharmaceutical companies on encouraging them to become mark |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-07-10 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Medicines and Healthcare products Regulatory Agency (MHRA) has not approached any pharmaceutical company to encourage them to become a marketing authorisation holder (MAH) for short-acting beta agonist (SABA) pressurised metered-dose inhalers (pMDIs) ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |